European Commission logo
European Commission

Development of antibodies and antibody-derived proteins for the prevention and treatment of infectious diseases with epidemic potential

Pays a fixed EUR 10 million grant to take antibody-based prophylactics and therapies for epidemic-prone viruses from preclinical testing into first-in-human trials.

ClosedEuropean CommissionUnited States

This Horizon Europe call pays for taking existing antibody or antibody-derived candidates -- not new discovery work -- through to first-in-human safety trials against a defined list of epidemic-prone viruses, including Lassa, Junin, Hantaan, Andes, Variola major, Hendra, Nipah and Venezuelan equine encephalitis. Proposals need to finish in vitro characterisation, run in vivo tests in at least one

This call funds development of existing antibody or antibody-derived protein candidates against at least one of a named list of epidemic-potential viruses (including Lassa, Hantaan, Andes, Sin Nombre, Variola major, Hendra, Nipah and Venezuelan equine encephalitis). Proposals must run in vitro and in vivo preclinical studies, produce GMP-quality test batches in the EU or EEA, and carry out first-in-human clinical safety studies with a clear regulatory pathway toward market authorisation.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€50M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →

More from European Commission

All grants from this funder →
European Commission logo
Open

Coordination for Cross-Sector Nuclear Technologies

🇪🇺European Commission · European Union

Funds coordination of European nuclear research platforms across energy, medicine, space, maritime uses and radiation protection.

Energy TechMedtech+2
€500KSep'26
European Commission logo
Open

Euratom Radiation Protection Partnership (PIANOFORTE)

🇪🇺European Commission · European Union

Funds PIANOFORTE’s 2026-27 continuation, an EU radiation-safety research partnership — only for its current members and any partner who joins them.

MedtechBiotech
€15MSep'26
European Commission logo
Open

European Stable Isotopes for Nuclear Medicine

🇪🇺European Commission · European Union

Funds industrial production of stable isotopes needed for radionuclide therapies and a more resilient European medical supply chain.

Medtech
€2MSep'26
European Commission logo
Open

Horizon Batteries: EV Recycling Pilot with India

🇪🇺European Commission · European Union

Funds a €9.4M lithium-ion battery recycling pilot line in India, matched to a separately funded Indian project on the same schedule.

Energy TechAdvanced Materials+2
€9.4MSep'26
European Commission logo
Open

Horizon Batteries: Sustainable Electrode Materials

🇪🇺European Commission · European Union

Funds four €7.1M projects that make battery electrode materials cleaner to produce — via greener refining or plant-based sourcing instead of mined graphite.

Energy TechAdvanced Materials+2
€7.1MSep'26
European Commission logo
Open

Horizon Buildings: Whole Life Carbon Data Platforms

🇪🇺European Commission · European Union

Funds three €5.25M projects that plug embodied and operational carbon data into building certificates, passports and BIM tools.

Built EnvironmentAI
€5.3MSep'26
Cystic Fibrosis Foundation logo
Open

CFF Mission Ventures Industry Investment

🇺🇸CFF · United States

Offers startup and industry teams with commercialization support for CFF Mission Ventures Industry Investment in biotechnology, medical technology, and synthetic biology.

BiotechMedtech+1
$5M – $25M
US Department of Health and Human Services logo
Open

Title X Family Planning Services Grants

🇺🇸HHS · United States

Supports family planning service providers across United States jurisdictions with grants that strengthen sexual health prevention, testing, counseling, and care.

MedtechBiotech
$200K – $22MJan'27
National Institute on Deafness and Other Communication Disorders logo
Open

Advancement and Innovation in Measurement of Language Development and Predictors

🇺🇸NIDCD · United States

Funds community-engaged language development measurement research for children under investigator-led initiatives in the United States.

BiotechMedtech+1
Oct'26
National Institute on Alcohol Abuse and Alcoholism logo
Open

Prevention and Intervention Approaches for FASD (R34)

🇺🇸NIAAA · United States

Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.

MedtechBiotech
$450KJan'27
National Institute on Alcohol Abuse and Alcoholism logo
Open

Prevention and Intervention Approaches for FASD (R61/R33)

🇺🇸NIAAA · United States

Supports translational research for FASD prevention and intervention, moving through feasibility and expansion milestones.

MedtechBiotech
Nov'26
National Institutes of Health logo
Open

Limited Competition: Intellectual and Developmental Disabilities Research Centers 2027

🇺🇸NIH · United States

Funds the renewal of NICHD's IDD research centres — about 15 awards from an $18 million pool. Only existing centres may apply.

BiotechMedtech
$800KOct'26